Ruhsitus

Ruhsitus Brand names, Ruhsitus Analogs

Ruhsitus Brand Names Mixture

No information avaliable

Ruhsitus Chemical_Formula

C₁₆H₁₃ClN₂O

Ruhsitus RX_link

http://www.rxlist.com/cgi/generic/diazepam.htm

Ruhsitus fda sheet

Ruhsitus msds (material safety sheet)

Ruhsitus MSDS

Ruhsitus Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Ruhsitus Molecular Weight

284.74 g/mol

Ruhsitus Melting Point

125-126^oC

Ruhsitus H₂O Solubility

Slightly soluble (50 mg/L)

Ruhsitus State

solid

Ruhsitus LogP

2.988

Ruhsitus Dosage Forms

Tablets; Injectable solution

Ruhsitus Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Ruhsitus Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Ruhsitus Absorption

Essentially complete, with a bioavailability of 93%.

Ruhsitus side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Ruhsitus Patient Information

Ruhsitus Organisms Affected

Humans and other mammals